C5orf47: A Potential Drug Target and Biomarker for Chromosome 5

Target Name: C5orf47

NCBI ID: G133491

C5orf47

Other Name(s): chromosome 5 open reading frame 47 | CE047_HUMAN | Uncharacterized protein C5orf47 | Chromosome 5 open reading frame 47

C5orf47: A Potential Drug Target and Biomarker for Chromosome 5

Chromosome 5 (C5) is one of the human chromosomes, which contain a large number of genes that play a vital role in various physiological processes. C5 is also home to a number of gene mutations, including missense mutations, which can lead to the development of various diseases, including cancer. In this article, we will discuss C5orf47, a gene located on chromosome 5 that has been identified as a potential drug target and biomarker for various diseases.

C5orf47: A Putative Drug Target

C5orf47 is a gene that encodes a protein named C5orf47. The protein is composed of 1,116 amino acids and has a calculated molecular weight of 12.5 kDa. C5orf47 is located in the open reading frame (ORF) of chromosome 5, which means that it spans the entire length of the 5th chromosome.

The C5orf47 gene has been shown to be involved in a number of cellular processes, including cell adhesion, migration, and the regulation of ion channels. It is also known to play a role in the development and progression of various diseases, including cancer.

C5orf47 as a Biomarker

One of the defining features of C5orf47 is its potential as a biomarker for various diseases. Its involvement in cell adhesion and migration makes it an attractive candidate for targeting processes that are involved in disease progression, such as cancer cell migration. Additionally, its role in regulating ion channels suggests that it may be involved in the regulation of electrical signals, which could be relevant to a number of diseases, including epilepsy.

C5orf47 has also been shown to be involved in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. This suggests that it may be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's.

C5orf47 as a Potential Drug Target

The potential drug target for C5orf47 is based on its involvement in the regulation of various cellular processes, including cell adhesion, migration, and apoptosis. Drugs that target these processes may be effective in treating a variety of diseases, including cancer, neurodegenerative diseases, and diseases associated with ion channel dysfunction.

One approach to targeting C5orf47 is to use small molecules that can modulate its activity. For example, drugs that inhibit the activity of ion channels on C5 may be effective in treating certain neurodegenerative diseases. Additionally, drugs that can modulate the level of cell apoptosis caused by C5 may be effective in treating certain diseases associated with apoptosis.

Conclusion

In conclusion, C5orf47 is a gene located on chromosome 5 that has been identified as a potential drug target and biomarker for various diseases. Its involvement in cell adhesion, migration, and the regulation of ion channels makes it an attractive candidate for targeting processes that are involved in disease progression. Additionally, its involvement in the regulation of cell apoptosis suggests that it may be involved in the development and progression of a variety of neurodegenerative diseases. Further research is needed to determine the effectiveness of drugs that target C5orf47 and to develop safe and effective treatments for diseases associated with its dysfunction.

Protein Name: Chromosome 5 Open Reading Frame 47

The "C5orf47 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C5orf47 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets